It had been observed in breast cancer that patients with elevated ICAM-1 tumor levels had a better survival, Regev et al found that while ICAM-1 deletion did not affect primary breast tumor growth, there was an increase in spontaneous metastasis to the lungs in ICAM-1 KO models. This evidence concerns the gene ICAM1 and breast cancer.